Kin Seng Liem
7PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jan 19, 2024
Addition of PEG-interferon to long-term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg-negative chronic hepatitis B: Multicentre Randomized Trial (PAS Study).Mina S Farag, Margo J H van Campenhout, M J Sonneveld
|Sep 01, 2022
Early virologic relapse predicts alanine aminotransferase flares after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B.Kin Seng Liem, Heng Chi, Scott Fung
|Sep 08, 2020
Maintained virological suppression and renal function with reduced dose tenofovir disoproxil fumarate in renally impaired chronic hepatitis B patients.Kin Seng Liem, David K Wong, Scott Fung
|Aug 30, 2019
Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study).Kin Seng Liem, Scott Fung, David K Wong
|Mar 27, 2019
Prevalence and predictors of complementary and alternative medicine modalities in patients with chronic hepatitis B.Kin Seng Liem, Colina Yim, Thomas D Ying
|Feb 13, 2019
Editorial: identifying candidates for pegylated interferon add-on to entecavir therapy in patients with HBeAg-positive chronic hepatitis B - authors' reply.Kin Seng Liem, Harry L A Janssen
Pageof 2
